Publication:
Activated platelet-derived microparticles in thalassaemia

dc.contributor.authorKovit Pattanapanyasaten_US
dc.contributor.authorSiriphan Gonwongen_US
dc.contributor.authorPorntip Chaichompooen_US
dc.contributor.authorEgarit Noulsrien_US
dc.contributor.authorSurada Lerdwanaen_US
dc.contributor.authorKasama Sukapiromen_US
dc.contributor.authorNoppadol Siritanaratkulen_US
dc.contributor.authorSuthat Fucharoenen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherThe Institute of Science and Technology for Research and Development, Mahidol Universityen_US
dc.date.accessioned2018-08-24T02:10:26Z
dc.date.available2018-08-24T02:10:26Z
dc.date.issued2007-02-01en_US
dc.description.abstractThromboembolic complications have been documented in thalassaemia patients. The aggregability of abnormal red blood cells and the high level of membrane-derived microparticles (MPs) stemming from blood cells are thought to be responsible for the associated thrombotic risk. We investigated the number of MPs, their cellular origin and their procoagulant properties in β-thalassaemia. Fresh whole blood was simultaneously stained for annexin V, cellular antigens and the known density beads. The procoagulant properties of these phosphatidylserine (PS)-bearing MPs were also measured by assessing the platelet factor-3-like activity in the blood. Flow cytometric results showed that splenectomised β-thalassaemia/HbE patients had significantly higher levels of PS-bearing MPs than non-splenectomised β-thalassaemia/HbE patients and normal individuals (P < 0·0001). There was a good correlation between PS-bearing MPs and PS-bearing platelets, reflecting the existence of chronic platelet activation in β-thalassaemia/HbE patients (rs = 0·511, P < 0·001). The cellular origin of PS-bearing MPs showed mostly activated-platelet origin with adhesion (CD41a/CD62P/CD36). Moreover, the platelet procoagulant activity was higher in splenectomised β-thalassaemia/HbE patients when compared with non-splenectomised (P < 0·05) and normal individuals (P < 0·01), and the amount correlated with PS-bearing MPs (rs = 0·560, P < 0·001). These findings suggest that MPs originate from activated platelets with a potential to aggravate thrombotic events when the numbers are excessive, as is commonly seen in splenectomised β-thalassaemia/HbE patients. © 2007 The Authors.en_US
dc.identifier.citationBritish Journal of Haematology. Vol.136, No.3 (2007), 462-471en_US
dc.identifier.doi10.1111/j.1365-2141.2006.06449.xen_US
dc.identifier.issn13652141en_US
dc.identifier.issn00071048en_US
dc.identifier.other2-s2.0-33846023689en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/25004
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846023689&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleActivated platelet-derived microparticles in thalassaemiaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846023689&origin=inwarden_US

Files

Collections